Recro Pharma Reports Inducement Grants for New Staff
Oct 31, 2017 11:00 am UTC| Business
MALVERN, Pa., Oct. 31, 2017 -- Recro Pharma, Inc. (Nasdaq:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for hospital and other acute care settings, today announced the expansion of...
Oct 31, 2017 11:01 am UTC| Business
Geneva, Switzerland and Boston, MA - October 31, 2017 - ObsEva SA (NASDAQ: OBSV), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions...
Oct 31, 2017 11:00 am UTC| Business
NEW HAVEN, Conn. and CHAPEL HILL, N.C., Oct. 31, 2017 -- Melinta Therapeutics, Inc., a privately held company developing and commercializing novel antibiotics to treat serious bacterial infections, and Cempra, Inc....
Broadwind Energy Announces Q3 2017 Results
Oct 31, 2017 11:00 am UTC| Business
Highlights: Q3 2017 orders of $18 million include sustained strong Gearing segment orders of $11 million and Process Systems segment orders of $5 million Q3 2017 revenue of $30 million in line with guidance – lower tower...
ProQR to Present at EuroTIDES Conference
Oct 31, 2017 11:00 am UTC| Business
LEIDEN, The Netherlands, Oct. 31, 2017 -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA medicines for the treatment of severe genetic rare...
AGTC to Host First Quarter Financial Results Conference Call and Webcast on November 7, 2017
Oct 31, 2017 11:00 am UTC| Business
GAINESVILLE, Fla. and CAMBRIDGE, Mass., Oct. 31, 2017 -- Applied Genetic Technologies Corporation (NASDAQ:AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene...
Colliers International reports strong results for third quarter
Oct 31, 2017 11:00 am UTC| Business
Operating highlights: Three months ended Nine months ended September 30 September 30(in millions of US$, except EPS)2017 2016 2017 2016 Revenues$574.1 $462.1 $1,541.1 $1,320.7Adjusted EBITDA (note...